~~<i id='411718F231'><strike id='411718F231'><tt id='411718F231'><pre id='411718F231'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：focus 2025-08-23 18:38:00 - browse：935

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Physician subsidies by hospitals soar in wake of No Surprises Act

leisure time

hotspot

entertainment

knowledge

Wikipedia

focus

3:53TheU.S.SupremeCourtisseenonJune23,2023inWashington,D.C.KevinDietsch/GettyImagesAunanimousSupreme

WSS

Testing for cancer recurrence creates a new limbo for patients

Paying for Covid pills will soon shift to insurers

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

FDA has safety concerns on CRISPR

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

ADA: All diabetes patients should be screened for liver condition

focus

knowledge

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: New research from Sanofi, Regeneron, etc.

23andMe had bad news about my health. I wish a person had delivered it

Senate panel to vote on hospitals, PBMs, prisoner care

Heart attack and stroke risk calculators need revising

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Alkermes shareholders re

Hospitals warn Medicare's drug payment fix is ‘unlawful’

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA has safety concerns on CRISPR

hotspot

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Synthetic human embryos? Researchers say term is overblown

Physician subsidies by hospitals soar in wake of No Surprises Act

Illumina to lay off 10% of research and development team

The simple reason for the increase in autism diagnosis

Brazil's Jair Bolsonaro is barred from running for office until 2030

entertainment

knowledge

Wikipedia

focus